CareDx, Inc. (CDNA) stock

CDNANasdaqServices-Medical LaboratoriesFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 12/3023% above fair value

$79.81−1.36 (-1.68%)

Close on Nov 12, 2026Market cap $4.19BP/E 33.4Yield –

CareDx statistics

83 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Feb 23, 2027 (estimated, after the close)
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 12, 2026

Valuation ratiosIndustry

Market Cap: $4.19B; $1.69B
Enterprise Value: $3.94B; $2.21B
PE Ratio: 33.39; 23.82
PS Ratio: 8.43; 1.54
PB Ratio: 8.97; 3.43
P/TBV Ratio: 20.36; 5.80
P/OCF Ratio: 60.76; 14.89

Enterprise valuationIndustry

EV / Sales: 7.93; 1.67
EV / EBITDA: 29.36; 15.40
EV / EBIT: 33.85; 20.39

Share statisticsIndustry

Shares Outstanding: 53M; 59M
Shares Change (YoY): -8.73%; 2.40%
Shares Change (QoQ): 1.90%; 0.33%
Float: 50M; 35M
Shares Held by Insiders: 4.77%; 15.2%
Shares Held by Institutions: 101.6%; 83.6%

Short sellingIndustry

Short Interest: 7M; –
Short Interest Change: 7.03%; -0.86%
Short % of Float: 14.4%; 6.37%
Short % of Shares Outstanding: 13.7%; 4.21%
Days to Cover: 5.28; 4.41

Stock price statisticsIndustry

52-Week High: $90.87; –
52-Week Low: $15.15; –
20-Day Moving Average: $76.07; –
50-Day Moving Average: $65.78; –
200-Day Moving Average: $36.42; –
Average True Range (14): $5.33; –
Price Change (1 Week): 4.56%; -0.16%
Price Change (1 Month): 23.4%; 0.10%
Price Change (3 Months): 76.1%; 1.86%
Price Change (6 Months): 289.5%; 15.1%
Price Change (YTD): 323.6%; 5.96%
Price Change (1 Year): 375.6%; 8.30%
Price Change (3 Years): 907.7%; 20.9%
Price Change (5 Years): 67.4%; -13.8%
Price Change (10 Years): 1895.3%; 187.3%
Average Volume (10 Days): 2M; –
Average Volume (20 Days): 1M; –
Average Volume (90 Days): 1M; –
Relative Volume: 0.52; 0.77
Relative Strength Index (14): 57.6; 46.5
Volatility (1 Year): 75.2%; 63.0%
Beta (5 Years): 1.51; 0.77

MarginsIndustry

Operating Margin: 23.4%; -2.98%
Pretax Margin: 25.0%; 2.12%
Profit Margin: 25.9%; -2.01%
EBITDA Margin: 27.0%; 3.36%

Returns on capitalIndustry

Return on Equity (ROE): 33.0%; 4.82%
Return on Assets (ROA): 24.0%; -3.06%
Return on Invested Capital (ROIC): 69.8%; 4.69%
Return on Capital Employed (ROCE): 23.2%; 0.40%

Financial positionIndustry

Current Ratio: 2.31; 1.41
Quick Ratio: 2.15; 0.99

GrowthIndustry

Revenue Growth (YoY): 38.9%; 9.63%
Net Income Growth (YoY): 82.6%; 16.5%
Revenue Growth (3Y CAGR): 5.68%; 11.3%
Revenue Growth (5Y CAGR): 14.6%; 12.6%

EfficiencyIndustry

Asset Turnover: 0.93; 0.81
Revenue Per Employee: $650.19K; $235.26K
Profits Per Employee: $168.14K; -$5.12K
Employee Count: 765; 910
WACC: 12.4%; 8.16%

Income statement (TTM)Industry

Revenue: $497.40M; $638.13M
Operating Income: $116.49M; -$675.66K
Pretax Income: $124.22M; -$575.82K
Net Income: $128.63M; -$1.48M
EBITDA: $134.29M; $1.43M
EPS (Diluted): $2.39; -$0.02

Balance sheetIndustry

Cash & Short-Term Investments: $250.48M; $98.48M
Net Cash (Debt): $250.48M; $119.40K
Net Cash Per Share: $4.77; $0.00
Equity (Book Value): $467.46M; $235.60M
Book Value Per Share: $8.90; $3.91
Tangible Book Value: $205.97M; $1.59M
Working Capital: $182.32M; $30.06M

Cash flow (TTM)Industry

Operating Cash Flow: $69.02M; $25.90M

Dividends and yieldsIndustry

Earnings Yield: 3.07%; 0.25%

Taxes and interestIndustry

Income Tax: -$4.41M; $564.50K
Effective Tax Rate: -3.55%; 24.1%

Scores and fair valueIndustry

Graham Number: $21.87; $21.25
Graham Upside: -72.6%; -49.9%
Altman Z-Score: 15.11; 2.24
Piotroski F-Score: 5; 5

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

Period	CDNA	S&P 500	Difference	CDNA per year	S&P 500 per year
1 month	+26.4%	-2.7%	+29.1 pts
3 months	+68.7%	-1.7%	+70.4 pts
Year to date	+323.6%	+11.9%	+311.7 pts
1 year	+389.3%	+12.0%	+377.3 pts
3 years	+977.1%	+78.2%	+898.9 pts	+120.8%	+21.2%
5 years	+67.4%	+73.2%	−5.9 pts	+10.9%	+11.6%
10 years	+1895.3%	+309.6%	+1585.6 pts	+34.9%	+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

7M CDNA shares were sold short on Oct 30, 2026, up 7.0% from the previous report, or 14.36% of the shares available to trade. At recent volumes it would take 5.3 days to buy them back. Over the last 20 sessions, 50.8% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	7,187,391	+7.0%	1,360,855	5.3
Oct 15, 2026	6,715,367	+1.9%	1,494,496	4.5
Sep 30, 2026	6,587,070	+4.6%	1,444,402	4.6
Sep 15, 2026	6,297,191	+8.0%	1,001,222	6.3
Aug 31, 2026	5,828,536	+0.7%	1,207,347	4.8
Aug 14, 2026	5,789,862	-5.6%	1,150,605	5.0
Jul 31, 2026	6,135,225	-0.8%	1,442,843	4.3
Jul 15, 2026	6,187,364	-25.8%	797,456	7.8
Jun 30, 2026	8,337,870	-1.1%	1,146,763	7.3
Jun 15, 2026	8,434,827	+32.4%	784,954	10.8
May 29, 2026	6,370,643	-2.1%	703,311	9.1
May 15, 2026	6,507,297	-5.6%	574,540	11.3